Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-10-19
2010-12-07
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S473000, C514S513000, C514S723000, C252S299610, C530S350000, C536S004100, C549S315000, C554S213000
Reexamination Certificate
active
07846903
ABSTRACT:
A cubic liquid crystal composition comprising at least one amphiphilic compound having the following general formula (1) and having an IV/OV value of 0.65 to 0.95, and water or an aqueous medium:wherein R represents a hydrophilic group; X and Y each independently represent a hydrogen atom or together form an oxygen atom; n is an integer of 0 to 4; and m is an integer of 0 to 3.
REFERENCES:
patent: 5143934 (1992-09-01), Lading et al.
patent: 61-137874 (1986-06-01), None
patent: 2001-328921 (2001-11-01), None
patent: 2002-20236 (2002-01-01), None
patent: 2002-226497 (2002-08-01), None
Definition “hydrophilic”, Merriam-Webster Online Dictionary, available at http://www.merriam-webster.com/dictionary/hydrophilic, last viewed Jul. 30, 2009.
Kouda, Yoshio and Shuppan, Sankyo, “Formulation Design iwth Organic Conception Diagram”, Nihon Emulsion Co., Ltd (2001), available at http://www.nihon-emulsion.co.jp/pdf/ocdbook—e.pdf.
Masakatsu Hato et al., “Aqueous phase behavior of A 1-ο- Phytanyl-β-D-Xyloside/Water System. Glycolipid-Based Biocontinuous Cubic Phases of Crystallographic Space Groups PN3M and IA3D.”, Langmuir, Dec. 21, 2004, p. 11366-11373, vol. 20, No. 26.
Thomas Abraham et al., “Polymer-Dispersed Bicontinuous Cubic Glycolipid Nanoparticles”, Biotechnology Progress, 2005, p. 255-262, vol. 21, No. 1.
Masakatsu Hato et al., “Alkylglycosides with an Isoprenoid-Type Hydrophobic Chain Can Afford Greater Control of Aqueous Phase Structures at Low Temperatures.”, Langmuir, 2002, pp. 3425-3429, vol. 18, No. 9.
Masakatsu Hato et al., “isoprenoid chain-type glycolipid (alkylglycoside): Formation of inverted cubic liquid crystals and structures thereof.”, The Chemical Society of Japan, Mar. 3, 2003, p. 383, 83rd, (1) , 4H2-13 with an English language abstract.
Thomas Abraham et al., “Glycolipid based cubic nanoparticles: preparation and structural aspects.”, Colloids and Surfaces B: Biointerfaces, May 15, 2004, p. 107-117, vol. 35, No. 2.
Itaru Yamashita et al., “Small angle X-ray scattering from lamellar phase for β-3,7- Dimethyloctylglucoside/water system”comparison with β-n-alkylglucosides., Colloids and Surfaces A: Physiochem. Eng. Aspects, Dec. 10, 2004, p. 485-490, vol. 250, Nos. 1-3.
Rajesh A. Salkar et al., “Alkylglucosides with isoprenoid-type hydrophobic chains—effects of Hydrophobic chain size on the aqueous behavior.”, Chemistry and Physics of Lipids, Jan. 2004, p. 65-75, vol. 127, No. 1.
Masakatsu Hato et al., “Novel Alkylpolyglycosides with Krafft temperatures of 0° C or lower.”, The Chemical Society of Japan, Mar. 15, 2001, p. 462, 79th(1) with an English language abstract.
Yohann Misquitta et al., “Rational design of lipid for membrane protein crystallization.”, Journal of Structural Biology, Nov. 2004, p. 169-175, vol. 148, No. 2.
Masakatsu Hato et al., “Glycolipid liquid crystals- structural regulation and application to membrane protein system”, The 55thDivisional Meeting on Colloid and Interface Chemistry, Sep. 2, 2002, p. 42 with an English language abstract.
Fujita Yoshiji
Hato Masakatsu
Ota Toshitaka
Shiono Manzo
Tanomura Masahisa
Cytopathfinder, Inc.
Jiang Shaojia Anna
Kuraray Co. Ltd.
National Institute of Advanced Industrial Science and Technology
Schmidtmann Bahar
LandOfFree
Type II cubic liquid crystal composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Type II cubic liquid crystal composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Type II cubic liquid crystal composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4209953